ArticleHealth economics review2020
A cost-effectiveness analysis model of Preventicus atrial fibrillation screening from the point of view of statutory health insurance in Germany.
Article in Health economics review, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.
- Health Economic Research Assessing the Value of Early Detection of Cardiovascular Disease: A Systematic Review.PharmacoEconomics · 2023Pooled it
- Mobile health solutions for atrial fibrillation detection and management: a systematic review.Clinical research in cardiology : official journal of the German Cardiac Society · 2022Pooled it
- Health economic evaluation of health promotion and disease prevention in Germany: a scoping review.Health economics review · 2026Review
- Screening for undiagnosed atrial fibrillation in community pharmacies using mobile electrocardiogram technology: a quasi-experimental cross-sectional study (PREVENIM ICTUS).BMC primary care · 2026Article
- Cost-effectiveness and budget impact analysis of switching from apixaban to rivaroxaban treatment among patients with nonvalvular atrial fibrillation in a German healthcare setting.Journal of comparative effectiveness research · 2025Article
- Fully Automated Photoplethysmography-Based Wearable Atrial Fibrillation Screening in a Hospital Setting.Diagnostics (Basel, Switzerland) · 2025Article
- Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands.European heart journal. Quality of care & clinical outcomes · 2023Article
- Cost-Effectiveness of Atrial Fibrillation Screening Strategies: A Systematic Review.Iranian journal of public health · 2023Review
- Economic and Performance Evaluation of E-Health before and after the Pandemic Era: A Literature Review and Future Perspectives.International journal of environmental research and public health · 2023Review
- Smartphone and wearable detected atrial arrhythmias in Older Adults: Results of a fully digital European Case finding study.European heart journal. Digital health · 2022Article
- How to use digital devices to detect and manage arrhythmias: an EHRA practical guide.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2022Article
- [Mobile health for detection of atrial fibrillation-Status quo and perspectives].Der Internist · 2022Review
- Cost-effectiveness of a photopethysmographic procedure for screening for atrial fibrillation in 6 European countries.Health economics review · 2022Article
- Remote Design of a Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study: Smart in OAC - AFNET 9.Frontiers in cardiovascular medicine · 2022Article
- Feasibility of digital atrial fibrillation screening in an elderly population : The Ulm heart rhythm weeks.Herzschrittmachertherapie & Elektrophysiologie · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWith atrial fibrillation (AF) the risk of stroke is 4.2-fold increased to a comparable population without AF. This risk decreases by up to 70% if AF is detected early enough and effective stroke preventive measures are taken as recommended by international guidelines. Long-term studies found large number of subjects with undiagnosed AF. Preventicus Heartbeats" is a hands-on screening tool for use on smartphone to diagnose AF with high sensitivity and specificity. The aim of this study is to research the cost-effectiveness of systematic screening for AF with this smartphone application.
methodEmploying a Markov model we analysed the cost-effectiveness of the "Preventicus Heartbeats" screening for Germany, i.e. from the perspective of German statutory sick funds.
resultsFor a cohort of 10,000 insured 75-year-old the use of the diagnostic app could avoid 60 strokes in the remaining lifetime thereof 32 strokes in the next four years. Former models have applied similar cohorts. The same cohort showed an increase in quality-adjusted life years (QALY) in the remaining lifetime of 165 QALYs in the scenario with screening versus. without screening and a decrease in discounted lifetime costs (including risk compensation effects) of €129 per participant (€148 for male, €114 for female participants).
conclusionsThe modelling demonstrates the health benefits and economic effects of an implementation of a systematic screening on AF with "Preventicus Heartbeats", given the perspective of the German payer, the statutory health care system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.